Use of Radiofrequency in Robot-Assisted Partial Nephrectomy for Small Tumors: A Novel Technique
Current Oncology · 2025
DOI: 10.3390/curroncol32050246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Matías Larrañaga und 10 weiteren Autor:innen. Beteiligte Einrichtung: Urology Intern Program, Faculty of Medicine, Finis Terrae University, Santiago 7501014, Chile. Hauptthemen laut MEDLINE: Nephrectomy, Kidney Neoplasms, Robotic Surgical Procedures, Radiofrequency Ablation. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction and Objectives: Radiofrequency is standardized for ablating small renal tumors, but evidence regarding its effects remains limited. Partial nephrectomy, the gold standard, often leads to hemorrhagic complications and irreversible renal damage due to hilum clamping. To mitigate these risks, we propose a novel technique that replaces clamping with radiofrequency ablation of the tumor for hemostasis in robot-assisted partial nephrectomy.
Methods
We report on 357 consecutive patients with T1a renal tumors treated with robot-assisted surgery between 2010 and July 2024. Radiofrequency was used peri-tumorally for hemostasis, followed by complete lesion enucleation. Follow-up included ultrasound and creatinine at 1 month, CT scans at months 3 and 9, and then annually for 5 years.
Results
The median age was 60.2 years, with 251 men (70.3%). The median tumor size was 22 mm, and the median blood loss was 15 mL. Hemorrhagic complications occurred in eight patients (2.2%), with one requiring a blood transfusion (0.28%). A total of 30 patients experienced transient stage 1 acute kidney disease (8.4%), with no significant change in median 74.92 mL/min/1.77 m2 vs. 78.77 mL/min/1.77 m2 vs. (p-value 0.15). The median follow-up was 48.2 months, with no tumor recurrence at the treated site. Renal cell carcinoma was found in 83.7% of tumors.
Conclusions
To our knowledge, this series represent the largest global undertaking of renal tumor treatment using peripheral radiofrequency ablation without clamping, demonstrating optimal surgical and oncological outcomes, lower morbidity, and fewer complications compared to those noted in the revised literature regarding traditional clamping techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Urology Intern Program, Faculty of Medicine, Finis Terrae University, Santiago 7501014, Chile.
- Urology Resident Program, Faculty of Medicine, Finis Terrae University, Santiago 7501014, Chile.
- Department of Urology, Santa María Clinic, Santiago 7520378, Chile.
- Department of Urology, Cleveland Clinic, Cleveland, OH 44195, USA.
- Department of Pathology, Santa María Clinic, Santiago 7520378, Chile.
ORCID-Profile: Matías Larrañaga, Rubén Olivares, Sergio Moreno
Zitieren
APA
Larrañaga, M., Ibañez, H., Pfeifer, J., Román, C., Olivares, R., Salvadó, J. A., Cabello, J. M., Moreno, S., Cabello, R., Franco, C., & Velasco, A. (2025). Use of Radiofrequency in Robot-Assisted Partial Nephrectomy for Small Tumors: A Novel Technique. Current Oncology. https://doi.org/10.3390/curroncol32050246
Vancouver
Larrañaga M, Ibañez H, Pfeifer J, Román C, Olivares R, Salvadó JA, et al. Use of Radiofrequency in Robot-Assisted Partial Nephrectomy for Small Tumors: A Novel Technique. Current Oncology. 2025. doi:10.3390/curroncol32050246
BibTeX
@article{Larraaga2025,
author = {Larrañaga, Matías and Ibañez, Helga and Pfeifer, Jessica and Román, Cristobal and Olivares, Rubén and Salvadó, José Antonio and Cabello, José Miguel and Moreno, Sergio and Cabello, Renato and Franco, Carmen and Velasco, Alfredo},
title = {Use of Radiofrequency in Robot-Assisted Partial Nephrectomy for Small Tumors: A Novel Technique},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32050246}
}
EUVIMED